Get started
Author

Fabian Stoll

Observed names: FABIAN D. STOLL, Fabian David Stoll, Stoll, Fabian
ORCID: 0000-0003-0891-4213
Observed ORCID: 0000-0003-0891-4213
OpenAlex ID: A5079322627
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
2022 · Anne Lautenbach, Marie Wernecke, et al. · Obesity Surgery · 95
PDF
Long-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery
2021 · Anne Lautenbach, Fabian Stoll, et al. · Obesity Surgery · 60
PDF
Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post‐bariatric treatment failure
2023 · Anne Lautenbach, Tobias Kantowski, et al. · Clinical Obesity · 33
PDF
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males
2023 · Stephanie Stanelle-Bertram, Sebastian Beck, et al. · Cell Reports Medicine · 28
PDF
NET Release of Long-Term Surviving Neutrophils
2022 · Jan Philipp Kolman, Laia Pagerols Raluy, et al. · Frontiers in Immunology · 26
PDF
Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition
2025 · Fabian Stoll, Tobias Kantowski, et al. · Obesity Research & Clinical Practice · 22
Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery
2022 · Anne Lautenbach, Marie Wernecke, et al. · International Journal of Obesity · 12
PDF
Bariatric Surgery Is Protective Against Renal Function Decline in Severely Obese Patients in the Long-Term
2020 · Anne Lautenbach, Jan-Wilhelm Wienecke, et al. · Obesity Surgery · 10
PDF
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery
2022 · Anne Lautenbach, Marie Wernecke, et al. · Obesity Surgery · 9
PDF
Sustained Weight Loss with Semaglutide once-weekly in Patients without Type 2 Diabetes and Postbariatric Treatment Failure
2023 · Anne Lautenbach, Tobias Kantowski, et al. · Diabetologie und Stoffwechsel · 1
1422-P: The Potential of Semaglutide Once-Weekly in Patients without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery
2022 · ANNE LAUTENBACH, MARIE WERNECKE, et al. · Diabetes · 1
369-OR: Continued Weight Loss with Semaglutide Once-Weekly in Patients without Type 2 Diabetes and Postbariatric Treatment Failure
2023 · ANNE LAUTENBACH, JONAS WAGNER, et al. · Diabetes
1421-P: Long-Term Type 2 Diabetes Remission after Bariatric Surgery in Patients with and without Liver Steatosis
2022 · ANNE LAUTENBACH, MARIE WERNECKE, et al. · Diabetes
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study
2021 · Schroeder, Maria, Schaumburg, Berfin, et al. · Figshare
67 Abfall des Thyreoidea-stimulierenden Hormons bei euthyreoten Patienten 8 Jahre nach bariatrischer OP
2021 · Anne Lautenbach, Marie Wernecke, et al. · Adipositas - Ursachen Folgeerkrankungen Therapie
65 Langfristige Verbesserung der chronischen Low-Grade-Inflammation nach bariatrischer Chirurgie
2021 · Anne Lautenbach, Fabian Stoll, et al. · Adipositas - Ursachen Folgeerkrankungen Therapie
Works count: 16
Citation count: 297
H-index: 9
I10-index: 8
Year
Topic
Type